| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/22/2001 | EP1124535A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/22/2001 | EP1124418A1 Use of gm-csf to inhibit development of drug resistance in hiv+ patients |
| 08/22/2001 | EP1105518A4 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
| 08/22/2001 | EP0949262B1 Cephem compounds |
| 08/22/2001 | EP0907633B1 New synthetic catechol derivatives, method for production and use thereof |
| 08/22/2001 | EP0799210B1 Piperazine-2,5-dione derivatives as modulators of multidrug resistance |
| 08/22/2001 | EP0777653B1 Dihygropyridine derivatives as bradykinin antagonists |
| 08/22/2001 | CN1309720A Virulence-associated nucleic acid sequences and uses thereof |
| 08/22/2001 | CN1309710A Genomic sequences upstream of coding region of IFN-alpha 2 gene for protein production and delivery |
| 08/22/2001 | CN1309708A Postweaning multisystemic wasting syndrome virus from pigs |
| 08/22/2001 | CN1309707A BASB029 polynucleotide(s) and polypeptides from i(neisseria meningitidis) |
| 08/22/2001 | CN1309706A Compound from moraxella catarrhalis |
| 08/22/2001 | CN1309666A Polymer composition of glucuronic acid glucosan |
| 08/22/2001 | CN1309664A Anti hepatitis C virus antibody and uses thereof |
| 08/22/2001 | CN1309662A Chemotaxis-inhibiting protein of i(staphylococcus) (CHIPS) and its use |
| 08/22/2001 | CN1309660A Phosphinous and phosphonic acid derivs. used as medicaments |
| 08/22/2001 | CN1309659A Phosphorous organic compounds and their use |
| 08/22/2001 | CN1309656A Thioalkyl alpha-substd. pyrimidine compounds |
| 08/22/2001 | CN1309651A Morpholino ethers |
| 08/22/2001 | CN1309633A Diacylhydrazine derivs. as integrain inhibitors |
| 08/22/2001 | CN1309568A Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having G chronic hepatitis C infection |
| 08/22/2001 | CN1309566A Nocathiacin antibiotics |
| 08/22/2001 | CN1309563A Use of 1-(aminoalkyl)-3-quinoxaline-2-one derives for preparation of compounds having antioxidant action |
| 08/22/2001 | CN1308956A Capsule for treating pulmonary tuberculosis |
| 08/22/2001 | CN1069895C Legionella specific antibiotic, microorganism producing antibiotic and process for producing same |
| 08/21/2001 | US6278013 Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives |
| 08/21/2001 | US6277985 As antibiotics; water solubility; in prodrugs |
| 08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
| 08/21/2001 | US6277971 Dna which codes for nap protein of defined amino acid sequence; diagnosis and treatment of acquired immune deficiency syndrome (aids) |
| 08/21/2001 | US6277962 Receptor on the surface of activated t-cells: act-4 |
| 08/21/2001 | US6277960 Amino acid sequence of g protein coupled receptor; treatment of eating disorders, asthma, parkinson's disease, cardiovascular and nervous system disorders, huntington's disease, tourett's syndrome, and others; diagnosis |
| 08/21/2001 | US6277891 Nitric oxide inhibits rhinovirus infection |
| 08/21/2001 | US6277860 Furopyridine antibacterials |
| 08/21/2001 | US6277843 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 08/21/2001 | US6277841 Quinoline ligands and metal complexes for diagnosis and therapy |
| 08/21/2001 | US6277839 Antiinflammatory agents, antipyretics, analgesics; side effect reduction |
| 08/21/2001 | US6277829 Dissolving azithromycin in solution of polybasic phosphate and citric acid; treatment of conjunctivitis, keratitis and blepharitis |
| 08/21/2001 | US6277827 Stability makes the novel species suitable for milling, compression and improved bioavailability; 2s-(4-(2, 5-dioxopyrrolidin-1-yl)-2s-mercaptobutyrylamino)-4-methylpenta noic acid (2,2-dimethyl-1s-methylcarbamoylpropyl)amide |
| 08/21/2001 | US6277821 For treating gramnegative and mycobacterium infections; endotoxin and heparin neutralization |
| 08/21/2001 | US6277631 Recombinant yeast (schizosaccharomyces pombe or saccharomyces cerevisiae) expression vectors |
| 08/21/2001 | US6277620 Polypeptide for the prevention of bacterial infection; bactericides; for vaccine development |
| 08/21/2001 | US6277561 Isolation and characterization of retrovirus from the hiv group via hybridization of oligonucleotide to nucleic acid indicating the presence of immunodeficiency virus (mvp-5180/91) |
| 08/21/2001 | US6277381 Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| 08/21/2001 | US6277380 Measles virus mutant antigen |
| 08/21/2001 | US6277379 Use of purified invaplex from gram negative bacteria as a vaccine |
| 08/21/2001 | US6277370 Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections and related method |
| 08/21/2001 | CA2097916C Subunit papillomavirus vaccine and peptides for use therein |
| 08/21/2001 | CA2094012C 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents |
| 08/21/2001 | CA2026143C Triazole compounds, their production and use |
| 08/16/2001 | WO2001059142A1 Antibody gene therapy with adeno-associated viral vectors |
| 08/16/2001 | WO2001059130A2 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | WO2001059129A2 Mammalian secreted group iii phospholipase a2 |
| 08/16/2001 | WO2001059126A2 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 08/16/2001 | WO2001059125A1 Method of constructing temperature-sensitive morbilli virus |
| 08/16/2001 | WO2001059123A1 Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis |
| 08/16/2001 | WO2001059106A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 08/16/2001 | WO2001059103A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | WO2001059084A1 Protein c derivatives |
| 08/16/2001 | WO2001059077A1 Porcine reproductive and respiratory syndrome virus and methods of use |
| 08/16/2001 | WO2001059071A2 Methods of preparing and using a viral vector library |
| 08/16/2001 | WO2001058956A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | WO2001058945A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | WO2001058937A2 Interferon-alpha induced genes |
| 08/16/2001 | WO2001058936A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/16/2001 | WO2001058935A2 FACTOR VII OR VIIa-LIKE MOLECULES |
| 08/16/2001 | WO2001058933A2 Selective n-acylation of a82846 glycopeptide analogs |
| 08/16/2001 | WO2001058916A2 Antibodies to ccr5 |
| 08/16/2001 | WO2001058915A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/16/2001 | WO2001058906A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058902A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058900A1 1h-imidazopyridine derivatives |
| 08/16/2001 | WO2001058897A1 Benzthiazoles as tnf and pde-iv inhibitors |
| 08/16/2001 | WO2001058896A1 Benzoxazole derivatives as tnf and pde iv inhibitors |
| 08/16/2001 | WO2001058895A1 Benzofuran carboxamides and their therapeutic use |
| 08/16/2001 | WO2001058893A2 Indol-3-yl derivatives and their use as integrin inhibitors |
| 08/16/2001 | WO2001058889A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 08/16/2001 | WO2001058885A1 Oxazolidinone thioamides with piperazine amide substituents |
| 08/16/2001 | WO2001058881A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 08/16/2001 | WO2001058877A1 Interferon ω production potentiators |
| 08/16/2001 | WO2001058876A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient |
| 08/16/2001 | WO2001058514A1 Drug delivery apparatus |
| 08/16/2001 | WO2001058485A2 Prophylactic and therapeutic antibodies against vaccina virus antigens |
| 08/16/2001 | WO2001058483A2 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES |
| 08/16/2001 | WO2001058471A2 Novel amino acid and peptide inhibitors of staphylococcus virulence |
| 08/16/2001 | WO2001058466A1 Biodegradable and biocompatible polymeric microspheres encapsulating salmonella enteritidisbacteria |
| 08/16/2001 | WO2001058461A1 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 08/16/2001 | WO2001058460A1 Isolation and transplantation of retinal stem cells |
| 08/16/2001 | WO2001058459A1 Remedies for hepatitis c |
| 08/16/2001 | WO2001058443A1 TNF- α INHIBITORS |
| 08/16/2001 | WO2001058283A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/16/2001 | WO2001058241A2 Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| 08/16/2001 | WO2001027282A8 Plant virus particles with exogenous internal eitopes |
| 08/16/2001 | WO2001024773B1 Liposome-entrapped dna oral vaccines |
| 08/16/2001 | WO2001023416A3 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 08/16/2001 | WO2001011024A3 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 08/16/2001 | WO2001010893A3 Il-16 antagonists |
| 08/16/2001 | WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 08/16/2001 | WO2001010429A3 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| 08/16/2001 | WO2001010413A3 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |